Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever.
about
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaFavipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.Novel drug discovery approaches for treating arenavirus infections.Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.Favipiravir (T-705) protects against Nipah virus infection in the hamster model.
P2860
Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Alterations in favipiravir (T- ...... el of viral hemorrhagic fever.
@ast
Alterations in favipiravir (T- ...... el of viral hemorrhagic fever.
@en
type
label
Alterations in favipiravir (T- ...... el of viral hemorrhagic fever.
@ast
Alterations in favipiravir (T- ...... el of viral hemorrhagic fever.
@en
prefLabel
Alterations in favipiravir (T- ...... el of viral hemorrhagic fever.
@ast
Alterations in favipiravir (T- ...... el of viral hemorrhagic fever.
@en
P2093
P2860
P1433
P1476
Alterations in favipiravir (T- ...... el of viral hemorrhagic fever.
@en
P2093
Brian B Gowen
Eric J Sefing
Jeffery O Hall
Jonna B Westover
Joseph Hagloch
Yousuke Furuta
P2860
P304
P356
10.1016/J.ANTIVIRAL.2015.07.003
P577
2015-07-14T00:00:00Z